1. Executive Summary |
2. Global Carrier Screening Market Introduction |
2.1. Global Carrier Screening Market – Taxonomy |
2.2. Global Carrier Screening Market –Definitions |
2.2.1. Method |
2.2.2. Type of Carrier Screening |
2.2.3. Medical Condition |
2.2.4. Technology |
2.2.5. End-User |
3. Global Carrier Screening Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Carrier Screening Market Dynamic Factors - Impact Analysis |
3.6. Global Carrier Screening Market – Competition Landscape |
4. Global Carrier Screening Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Carrier Screening Market Forecast, By Method, 2017 - 2021 and Forecast, 2022 - 2028 |
5.1. Molecular Screening Test |
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Biochemical Screening Test |
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Carrier Screening Market Forecast, By Type of Carrier Screening, 2017 - 2021 and Forecast, 2022 - 2028 |
6.1. Expanded Carrier Screening |
6.1.1. Customized Panel Testing |
6.1.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.1.3. Market Opportunity Analysis |
6.1.2. Predesigned Panel Testing |
6.1.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.2.3. Market Opportunity Analysis |
6.2. Targeted Disease Carrier Screening |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Carrier Screening Market Forecast, By Medical Condition, 2017 - 2021 and Forecast, 2022 - 2028 |
7.1. Cystic Fibrosis |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Fragile X-Syndrome |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Sickele Cell Disease |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Spinal Muscular Atrophy |
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Alphathalassemia |
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Other Conditions (Tay Scah Disease) |
7.6.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
7.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.6.3. Market Opportunity Analysis |
8. Global Carrier Screening Market Forecast, By Technology, 2017 - 2021 and Forecast, 2022 - 2028 |
8.1. Polymerase Chain Reaction (PCR) |
8.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. DNA Sequencing |
8.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Microarrays |
8.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Other Technologies |
8.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9. Global Carrier Screening Market Forecast, By End-User, 2017 - 2021 and Forecast, 2022 - 2028 |
9.1. Hospitals |
9.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Reference Laboratories |
9.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Physician Offices & Clinics |
9.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Other End Users |
9.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
10. Global Carrier Screening Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)Â |
10.1. North America |
10.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
10.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.1.3. Market Opportunity Analysis |
10.2. Europe |
10.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
10.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.2.3. Market Opportunity Analysis |
10.3. Asia-Pacific |
10.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
10.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.3.3. Market Opportunity Analysis |
10.4. Latin America |
10.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
10.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.4.3. Market Opportunity Analysis |
10.5. Middle East and Africa |
10.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn) |
10.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
10.5.3. Market Opportunity Analysis |
10.6. Global Carrier Screening Market - Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Region, 2022 - 2028 |
11. North America Carrier Screening Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)Â |
11.1. By Method Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.1.1. Molecular Screening Test |
11.1.2. Biochemical Screening Test |
11.2. By Type of Carrier Screening Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Expanded Carrier Screening |
11.2.1.1. Customized Panel Testing |
11.2.1.2. Predesigned Panel Testing |
11.2.2. Targeted Disease Carrier Screening |
11.3. By Medical Condition Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Cystic Fibrosis |
11.3.2. Fragile X-Syndrome |
11.3.3. Sickele Cell Disease |
11.3.4. Spinal Muscular Atrophy |
11.3.5. Alphathalassemia |
11.3.6. Other Conditions (Tay Scah Disease) |
11.4. By Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.4.1. Polymerase Chain Reaction (PCR) |
11.4.2. DNA Sequencing |
11.4.3. Microarrays |
11.4.4. Other Technologies |
11.5. By End-User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.5.1. Hospitals |
11.5.2. Reference Laboratories |
11.5.3. Physician Offices & Clinics |
11.5.4. Other End Users |
11.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.6.1. USA |
11.6.2. Canada |
11.7. North America Carrier Screening Market - Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 - 2028 |
11.8. North America Carrier Screening Market Dynamics – Trends |
12. Europe Carrier Screening Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)Â |
12.1. By Method Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.1.1. Molecular Screening Test |
12.1.2. Biochemical Screening Test |
12.2. By Type of Carrier Screening Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Expanded Carrier Screening |
12.2.1.1. Customized Panel Testing |
12.2.1.2. Predesigned Panel Testing |
12.2.2. Targeted Disease Carrier Screening |
12.3. By Medical Condition Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Cystic Fibrosis |
12.3.2. Fragile X-Syndrome |
12.3.3. Sickele Cell Disease |
12.3.4. Spinal Muscular Atrophy |
12.3.5. Alphathalassemia |
12.3.6. Other Conditions (Tay Scah Disease) |
12.4. By Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.4.1. Polymerase Chain Reaction (PCR) |
12.4.2. DNA Sequencing |
12.4.3. Microarrays |
12.4.4. Other Technologies |
12.5. By End-User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.5.1. Hospitals |
12.5.2. Reference Laboratories |
12.5.3. Physician Offices & Clinics |
12.5.4. Other End Users |
12.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.6.1. Germany |
12.6.2. UK |
12.6.3. France |
12.6.4. Spain |
12.6.5. Italy |
12.6.6. Russia |
12.6.7. Poland |
12.6.8. Rest of Europe |
12.7. Europe Carrier Screening Market - Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 - 2028 |
12.8. Europe Carrier Screening Market Dynamics – Trends |
13. Asia-Pacific Carrier Screening Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)Â |
13.1. By Method Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.1.1. Molecular Screening Test |
13.1.2. Biochemical Screening Test |
13.2. By Type of Carrier Screening Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.2.1. Expanded Carrier Screening |
13.2.1.1. Customized Panel Testing |
13.2.1.2. Predesigned Panel Testing |
13.2.2. Targeted Disease Carrier Screening |
13.3. By Medical Condition Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.3.1. Cystic Fibrosis |
13.3.2. Fragile X-Syndrome |
13.3.3. Sickele Cell Disease |
13.3.4. Spinal Muscular Atrophy |
13.3.5. Alphathalassemia |
13.3.6. Other Conditions (Tay Scah Disease) |
13.4. By Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.4.1. Polymerase Chain Reaction (PCR) |
13.4.2. DNA Sequencing |
13.4.3. Microarrays |
13.4.4. Other Technologies |
13.5. By End-User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
13.5.1. Hospitals |
13.5.2. Reference Laboratories |
13.5.3. Physician Offices & Clinics |
13.5.4. Other End Users |
13.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
13.6.1. Japan |
13.6.2. China |
13.6.3. India |
13.6.4. ASEAN |
13.6.5. Australia & New Zealand |
13.6.6. Rest of Asia-Pacific |
13.7. Asia-Pacific Carrier Screening Market - Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 - 2028 |
13.8. Asia-Pacific Carrier Screening Market Dynamics – Trends |
14. Latin America Carrier Screening Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)Â |
14.1. By Method Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.1.1. Molecular Screening Test |
14.1.2. Biochemical Screening Test |
14.2. By Type of Carrier Screening Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.2.1. Expanded Carrier Screening |
14.2.1.1. Customized Panel Testing |
14.2.1.2. Predesigned Panel Testing |
14.2.2. Targeted Disease Carrier Screening |
14.3. By Medical Condition Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.3.1. Cystic Fibrosis |
14.3.2. Fragile X-Syndrome |
14.3.3. Sickele Cell Disease |
14.3.4. Spinal Muscular Atrophy |
14.3.5. Alphathalassemia |
14.3.6. Other Conditions (Tay Scah Disease) |
14.4. By Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.4.1. Polymerase Chain Reaction (PCR) |
14.4.2. DNA Sequencing |
14.4.3. Microarrays |
14.4.4. Other Technologies |
14.5. By End-User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
14.5.1. Hospitals |
14.5.2. Reference Laboratories |
14.5.3. Physician Offices & Clinics |
14.5.4. Other End Users |
14.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
14.6.1. Brazil |
14.6.2. Mexico |
14.6.3. Argentina |
14.6.4. Rest of Latin America |
14.7. Latin America Carrier Screening Market - Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 - 2028 |
14.8. Latin America Carrier Screening Market Dynamics – Trends |
15. Middle East and Africa Carrier Screening Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)Â |
15.1. By Method Type Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.1.1. Molecular Screening Test |
15.1.2. Biochemical Screening Test |
15.2. By Type of Carrier Screening Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.2.1. Expanded Carrier Screening |
15.2.1.1. Customized Panel Testing |
15.2.1.2. Predesigned Panel Testing |
15.2.2. Targeted Disease Carrier Screening |
15.3. By Medical Condition Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.3.1. Cystic Fibrosis |
15.3.2. Fragile X-Syndrome |
15.3.3. Sickele Cell Disease |
15.3.4. Spinal Muscular Atrophy |
15.3.5. Alphathalassemia |
15.3.6. Other Conditions (Tay Scah Disease) |
15.4. By Technology Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.4.1. Polymerase Chain Reaction (PCR) |
15.4.2. DNA Sequencing |
15.4.3. Microarrays |
15.4.4. Other Technologies |
15.5. By End-User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
15.5.1. Hospitals |
15.5.2. Reference Laboratories |
15.5.3. Physician Offices & Clinics |
15.5.4. Other End Users |
15.6. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
15.6.1. Gulf Cooperation Council (GCC) Countries |
15.6.2. Israel |
15.6.3. South Africa |
15.6.4. Rest of MEA |
15.7. MEA Carrier Screening Market - Opportunity Analysis Index, By Method, By Type of Carrier Screening, By Medical Condition, By Technology, By End-User and Country, 2022 - 2028 |
15.8. MEA Carrier Screening Market Dynamics – Trends |
16. Competition Landscape |
16.1. Strategic Dashboard of Top Market Players |
16.2. Company Profiles (Introduction, Financial Analysis, Material & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
16.2.1. Plastixx FFS Technologies |
16.2.2. Centogene N.V |
16.2.3. LifeCell International Pvt. Ltd. |
16.2.4. Thermo Fisher Scientific Inc. |
16.2.5. 23Andme Inc. |
16.2.6. F. Hoffmann-La Roche AG |
16.2.7. Abbott Laboratories |
16.2.8. Illumina Inc. |
16.2.9. Autogenomics Inc. |
16.2.10. Myriad Genetics |
16.2.11. Cepheid (Danaher Corporation) |
16.2.12. Luminex Corporation |
16.2.13. Sequenom Inc. (Laboratory Corporation of America Holdings) |
17. Research Methodology |
18. Key Assumptions and Acronyms |